You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IPSS-R low

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

Anemia in MDS Trial in Plantation, Bronx, Austin (TP-0184)

Completed
  • Anemia in Myelodysplastic Syndromes
  • Plantation, Florida
  • +2 more
Apr 4, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Chronic Myelomonocytic Leukemia Trial in Houston

Recruiting
  • Chronic Myelomonocytic Leukemia
  • +5 more
  • Canakinumab
  • Houston, Texas
    M D Anderson Cancer Center
Dec 7, 2022

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

Recruiting
  • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
  • Ocala, Florida
  • +3 more
Jan 30, 2023

Anemia Trial (Luspatercept)

Not yet recruiting
  • Anemia
  • Luspatercept
  • (no location specified)
May 26, 2023

Anemia, MDS Trial in Germany (Canakinumab Injection)

Recruiting
  • Anemia
  • Myelodysplastic Syndromes
  • Canakinumab Injection
  • Berlin, Germany
  • +5 more
Nov 8, 2022

MDS Trial in China, Japan (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
  • +33 more
Aug 16, 2022

MDS Trial in Worldwide (Luspatercept, Epoetin Alfa)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Luspatercept
  • Epoetin Alfa
  • Concord, California
  • +100 more
Jul 20, 2023

Non-specific Low Back Pain Trial (Multimodal Exercises and Education delivered through tele rehabilitation, Selafcare)

Not yet recruiting
  • Non-specific Low Back Pain
  • Multimodal Exercises and Education delivered through tele rehabilitation
  • Selafcare
  • (no location specified)
Oct 15, 2023

Lower Risk MDS Per IPSS-R Trial (Luspatercept)

Not yet recruiting
  • Lower Risk MDS Per IPSS-R
  • (no location specified)
Jun 21, 2023

Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts) Trial in Worldwide (FG-4592, Placebo)

Active, not recruiting
  • Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)
  • Los Angeles, California
  • +71 more
Sep 16, 2022

MDS Trial in Worldwide (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Los Alamitos, California
  • +53 more
Sep 13, 2023

Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between

Recruiting
  • Prostate Cancer
  • +5 more
  • grade and compare reported side effects between groups
  • Quebec, Canada
    CHUdeQuebec
Mar 14, 2023

Diffuse Large B Cell Lymphoma, Relapse/Recurrence, Extranodal Extension Trial in Beijing (Low-Dose Decitabine plus anti-PD-1)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • Low-Dose Decitabine plus anti-PD-1
  • Beijing, Beijing, China
    ChinaPLAGH
Apr 18, 2023

Diffuse Large B-cell Lymphoma Trial in Shanghai (Rituximab, Cyclophosphamide, Epirubicin)

Active, not recruiting
  • Diffuse Large B-cell Lymphoma
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 1, 2022

MDS Trial in Worldwide (Luspatercept, Placebo)

Completed
Has Results
  • Myelodysplastic Syndromes
  • Stanford, California
  • +73 more
Nov 19, 2021

MDS Trial in Worldwide (MBG453, Placebo, Hypomethylating agents)

Active, not recruiting
  • Myelodysplastic Syndromes
  • Duarte, California
  • +46 more
Jan 20, 2023

MDS and Allogeneic Stem Cell Transplantation Trial in Perugia (MDS and AlloHSCT)

Recruiting
  • MDS and Allogeneic Stem Cell Transplantation
  • MDS and AlloHSCT
  • Perugia, PG, Italy
    University of Perugia
Mar 11, 2021

Acute Myeloid Leukemia Trial in Suzhou (CAV Regimen, MEC Regimen)

Recruiting
  • Acute Myeloid Leukemia
  • CAV Regimen
  • MEC Regimen
  • Suzhou, Jiangsu, China
    The First Affliated Hospital of Soochow University
Dec 22, 2022

Prostate Cancer Trial in Roma (Soractelite Echolaser Transperineal focal laser ablation)

Recruiting
  • Prostate Cancer
  • Soractelite Echolaser Transperineal focal laser ablation
  • Roma, RM, Italy
    San Carlo di Nancy Hospital
Oct 16, 2022

MDS, CMML Trial in Florence (CC-486)

Recruiting
  • MDS
  • CMML
  • Florence, Italy
    AOU Careggi- University of Florence
Mar 16, 2021

Low Mood, Depressive Symptoms Trial in Cork (Bifidobacterium longum 1714® strain, Placebo)

Completed
  • Low Mood
  • Depressive Symptoms
  • Bifidobacterium longum 1714® strain
  • Placebo
  • Cork, Ireland
    Atlantia Food Clinical Trials
Nov 9, 2022

Myelodysplastic Syndrome (MDS) Trial in Worldwide (sabatolimab, azacitidine, venetoclax)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Brasschaat, Belgium
  • +9 more
Jan 19, 2023

Acute Lymphoblastic Leukemia Trial in Suzhou (cladribine, cytarabine,venetoclax)

Recruiting
  • Acute Lymphoblastic Leukemia
  • cladribine, cytarabine,venetoclax
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 22, 2022